Surveillance benefit arteriovenous graft

(A) Nonrandomized studies that reported graft thrombosis rates during a historical control period and after implementing monitoring or surveillance. All studies reported that thrombosis decreased during monitoring or surveillance.
(B) Rates of graft thrombosis in graft surveillance group and control group in randomized controlled trials. Thrombosis rates were not significantly different between groups.